Is Viking Therapeutics Stock Really Going to $125?
Source: Motley Fool
2026-02-19 15:43:00 ET
Most veteran investors can attest that, although they're also often a complete bust, every now and then a biopharma stock dishes out a windfall gain.
That's what the analyst community seems to expect from Viking Therapeutics (NASDAQ: VKTX) in the foreseeable future. The stock's current consensus price target of $92.94 is more than 200% above the ticker's present price, while one analyst -- BTIG's Justin Zelin -- says this stock's worth $125. That's more than 300% above its current value.
The question is, what do so many stock-picking pros see in this extremely unprofitable pharmaceutical start-up?
Viking Therapeutics Inc.
NASDAQ: VKTX
VKTX Trading
4.94% G/L:
$33.33 Last:
861,899 Volume:
$32.87 Open:
VKTX Latest News
March 09, 2026 10:20:00 am
Forget AI Stocks: This Potentially Disruptive Biotech Could Soar By 181%, According to Wall Street
February 23, 2026 08:50:00 pm
Got $5,000? Viking Therapeutics Might Be a Weight?Loss Drug Moon Shot in the Making.
February 23, 2026 05:30:00 am
3 Reasons Viking Therapeutics Stock Could 10X if Its Obesity Pipeline Succeeds
VKTX Stock Data
$3,277,488,794
108,401,854
0.69%
178
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
